- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Improved needle guide avoids deflection
Suros Surgical Systems of Indianapolis has designed a new needle guide for use with its ATEC breast biopsy and excision system and Lorad stereotactic tables. The new guide virtually eliminates the long-time problem of needle-tip deflection with
Suros Surgical Systems of Indianapolis has designed a new needle guide for use with its ATEC breast biopsy and excision system and Lorad stereotactic tables. The new guide virtually eliminates the long-time problem of needle-tip deflection with vacuum-assisted biopsy devices, according to the company. The guide captures the shaft of the needle in a 360º radius, minimizing the possibility of needle deflection that often affects postfire needle accuracy. The new Suros product complements an existing line of needle guides offered for use with the Fischer and Instrumentarium stereotactic tables. It is compatible with ultrasound, stereotactic, and MRI guidance.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
